Skip to content

Comparison of the effect of low-level red light and 0.01% atropine eyedrops in myopia control

Comparison of the effect of low-level red light and 0.01% atropine in myopia control

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045834
Enrollment
Unknown
Registered
2021-04-25
Start date
2021-05-06
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Intervention group:Low-level red light therapy
Control group:0.01% atropine eyedrops

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1.Aged 7 to 15 years; 2.Myopic children (cycloplegic spherical equivalent of -1.0D or greater and cylinder of 2.5D or less in both eyes) 3.Best corrected visual aquity of 1.0 or more; 4.Agree to random grouping.

Exclusion criteria

Exclusion criteria: 1. Children who have used low-concentration atropine eye drops (0.01%-0.5%) or orthokeratology for myopia control; 2. Children with anisometropia (the diopter difference between the two eyes is> 1.50D), strabismus, and amblyopia; 3. Suffer from congenital eye diseases, such as congenital cataracts and congenital retinal diseases; 4. Secondary myopia (such as having suffered from retinopathy of prematurity or other eye diseases in infants and young children leading to secondary myopia), or myopia with systemic syndrome (such as those with Marfan syndrome); 5. Those who have undergone myopia correction surgery (such as LASIK, etc.), internal eye surgery (such as cataract extraction, intraocular lens implantation, etc.); 6. Those with turbid refractive media (such as corneal disease, turbid crystals, etc.); 7. Patients with active ocular surface inflammatory disease.

Design outcomes

Secondary

MeasureTime frame
center corneal thickness;anterior chamber depth;corneal curvature;Spherical equivalent;presenting visual acuity;best corrected visual acuity;

Primary

MeasureTime frame
axial length;

Countries

China

Contacts

Public ContactLi Jinying

Peking University Shenzhen Hospital

ljyszbdyy@163.com+86 13510331648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026